HOME>CSR>GRI Standard Comparative Table

GRI Standard Comparative Table

  Disclosure Page
General Disclosures
1. Organizational profile
GRI 102 : General Disclosures 2016 102-1 Name of the organization Corporate Data
102-2 Activities, brands, products, and services Corporate Data
102-3 Location of headquarters Corporate Data
102-4 Location of operations Network
Group Companies
102-5 Ownership and legal form Corporate Data
102-6 Markets served Corporate Report 2017, page5
The Power of Change
Annual Securities Report
(Overview of company, Status of businesses) (Japanese only)
102-7 Scale of the organization Corporate Data
Corporate Report 2017, page5, 10
The Power of Change, Financial and Non-Financial Highlights
Annual Securities Report
(Overview of company) (Japanese only)
102-8 Information on employees and other workers Data
102-10 Significant changes to the organization and its supply chain Annual Securities Report
(Status of businesses) (Japanese only)
102-11 Precautionary Principle or approach Risk Management
Quality and Reliability Assurance
Environmental Management
Energy Conservation and Global Warming Mitigation
Waste Reduction & Proper Management of Chemical Substances
102-12 External initiatives United Nations Global Compact
102-13 Membership of associations Japan Business Federation (Keidanren), The Federation of Pharmaceutical Manufacturers' Association of JAPAN (F P M A J), The Japan Pharmaceutical Manufacturers Association (JPMA), etc.
2. Strategy
  102-14 Statement from senior decision-maker Message from the Management
Corporate Report 2017, page14-20
Message from the President
102-15 Key impacts, risks, and opportunities Consumer Issues
Annual Securities Report
(Business risks) (Japanese only)
3. Ethics and integrity
  102-16 Values, principles, standards, and norms of behavior Corporate Information (Philosophy and Vision,Corporate Behavior Charter, CODE OF CONDUCT)
102-17 Mechanisms for advice and concerns about ethics Corporate Information (Establishment of Internal System to Address Improper Use of Public Research Expenses and Improper Research) (Japanese only)
Compliance
Initiatives for Employees
4. Governance
  102-18 Governance structure Corporate Governance
102-19 Delegating authority Environmental Management
102-22 Composition of the highest governance body and its committees Corporate Governance
Corporate Governance Report
Corporate Report 2017, page56, 59, 62-65
Corporate Governance and Internal Control, Board of Directors and Auditors
102-23 Chair of the highest governance body Corporate Governance Report
102-24 Nominating and selecting the highest governance body Corporate Governance Policy of Mitsubishi Tanabe Pharma Corporation
102-25 Conflicts of interest Corporate Governance Policy of Mitsubishi Tanabe Pharma Corporation
Corporate Governance Report
102-26 Role of highest governance body in setting purpose, values, and strategy Corporate Report 2017, page19-20
Message from the President
102-27 Collective knowledge of highest governance body Corporate Report 2017, page 58-59, 62-65
Messages from Outside Directors, Board of Directors and Auditors
102-28 Evaluating the highest governance body's performance Corporate Governance Report
102-29 Identifying and managing economic, environmental, and social impacts Corporate Governance
Risk Management
Environmental Management
102-30 Effectiveness of risk management processes Risk Management
Environmental Management
102-31 Review of economic, environmental, and social topics Risk Management
102-33 Communicating critical concerns Corporate Governance
Risk Management
Environmental Management
102-35 Remuneration policies Corporate Governance Report
Corporate Report 2017, page 57
Corporate Governance and Internal Control
102-36 Process for determining remuneration Corporate Governance Report
Corporate Report 2017, page 57
Corporate Governance and Internal Control
5. Stakeholder engagement
  102-40 List of stakeholder groups Mitsubishi Tanabe Pharma's CSR
102-41 Collective bargaining agreements Promoting Diversity
Annual Securities Report
(Status of employees) (Japanese only)
102-43 Approach to stakeholder engagement Corporate Governance
Occupational Health and Safety
Human Rights Issues in the Value Chain
Promoting Diversity
Promotion of Environmental Communication
Promotion of CSR Procurement
Information Provision
Support for Medical Treatment and Health
Contributing to Local Communities
102-44 Key topics and concerns raised Occupational Health and Safety
Human Rights Issues in the Value Chain
Information Provision
6. Reporting practice
  102-45 Entities included in the consolidated financial statements Corporate Report 2017, page 92
Corporate Data / Investor Information
Annual Securities Report
(Business activities, Status of subsidiaries and affiliates) (Japanese only)
102-46 Defining report content and topic Boundaries Editorial Policies
Environmental Management
102-48 Restatements of information Not applicable
102-49 Changes in reporting Not applicable
102-50 Reporting period Editorial Policies
102-51 Date of most recent report Editorial Policies
102-52 Reporting cycle Editorial Policies
102-53 Contact point for questions regarding the report Editorial Policies
102-54 Claims of reporting in accordance with the GRI Standards Not applicable
102-55 GRI content index This GRI Standard Comparative Table
102-56 External assurance Overview of Environmental Impact / Independent Third-Party Assurance Report
Material topics
GRI 103 : Management Approach 2016 103-2 The management approach and its components Mitsubishi Tanabe Pharma's CSR
103-3 Evaluation of the management approach Organizational Governance
Human Rights
Labor Practices
Environment
Fair Operating Practices
Consumer Issues
Community Involvement and Development
Economic
Economic Performance
GRI 201 : Economic Performance 2016 201-1 Direct economic value generated and distributed Annual Securities Report
(Japanese only)
201-2 Financial implications and other risks and opportunities due to climate change Energy Conservation and Global Warming Mitigation
201-3 Defined benefit plan obligations and other retirement plans Annual Securities Report
(Status of accounting ) (Japanese only)
201-4 Financial assistance received from government Annual Securities Report
(Status of accounting ) (Japanese only)
Anti-corruption
GRI 205 : Anti-corruption 2016 205-1 Operations assessed for risks related to corruption Prevention of Bribery and Corruption
205-2 Communication and training about anti-corruption policies and procedures Prevention of Bribery and Corruption
Compliance
205-3 Confirmed incidents of corruption and actions taken Not applicable
Anti-competitive Behavior
GRI 206 : Anti-competitive Behavior 2016 206-1 Legal actions for anti-competitive behavior, anti-trust, and monopoly practices Not applicable
Environmental
Materials
GRI 301 : Materials 2016 301-1 Materials used by weight or volume Overview of Environmental Impact / Independent Third-Party Assurance Report
Energy
GRI 302 : Energy 2016 302-1 Energy consumption within the organization Overview of Environmental Impact / Independent Third-Party Assurance Report
Energy Conservation and Global Warming Mitigation
302-4 Reduction of energy consumption Energy Conservation and Global Warming Mitigation
Water
GRI 303 : Water 2016 303-1 Water withdrawal by source Waste Reduction & Proper Management of Chemical Substances
Biodiversity
GRI 304 : Biodiversity 2016 304-3 Habitats protected or restored Promotion of Environmental Communication
Emissions
GRI 305 : Emissions 2016 305-1 Direct (Scope 1) GHG emissions Overview of Environmental Impact / Independent Third-Party Assurance Report
Energy Conservation and Global Warming Mitigation
305-2 Energy indirect (Scope 2) GHG emissions Overview of Environmental Impact / Independent Third-Party Assurance Report
Energy Conservation and Global Warming Mitigation
305-3 Other indirect (Scope 3) GHG emissions Overview of Environmental Impact / Independent Third-Party Assurance Report
Energy Conservation and Global Warming Mitigation
305-5 Reduction of GHG emissions Energy Conservation and Global Warming Mitigation
305-7 Nitrogen oxides (NOX), sulfur oxides (SOX), and other significant air emissions Overview of Environmental Impact / Independent Third-Party Assurance Report
Effluents and Waste
GRI 306 : Effluents and Waste 2016 306-1 Water discharge by quality and destination Overview of Environmental Impact / Independent Third-Party Assurance Report
306-2 Waste by type and disposal method Waste Reduction & Proper Management of Chemical Substances
306-3 Significant spills Environmental Management
Environmental Compliance
GRI 307 : Environmental Compliance 2016 307-1 Non-compliance with environmental laws and regulations Environmental Management
Social
Employment
GRI 401 : Employment 2016 401-1 New employee hires and employee turnover Data
401-3 Parental leave Promoting Diversity
Data
Occupational Health and Safety
GRI 403 : Occupational Health and Safety 2016 403-1 Workers representation in formal joint management?worker health and safety committees There is worker participation.
403-2 Types of injury and rates of injury, occupational diseases, lost days, and absenteeism, and number of work-related fatalities Occupational Health and Safety
Data
Training and Education
GRI 404 : Training and Education 2016 404-2 Programs for upgrading employee skills and transition assistance programs Human Resources Development
Diversity and Equal Opportunity
GRI 405 : Diversity and Equal Opportunity 2016 405-1 Diversity of governance bodies and employees Data
Rights of Indigenous Peoples
GRI 411 : Rights of Indigenous Peoples 2016 411-1 Incidents of violations involving rights of indigenous peoples Not applicable
Human Rights Assessment
GRI 412 : Human Rights Assessment 2016 412-2 Employee training on human rights policies or procedures Initiatives for Employees
Local Communities
GRI 413 : Local Communities 2016 413-1 Operations with local community engagement, impact assessments, and development programs Contributing to Local Communities
Customer Health and Safety
GRI 416 : Customer Health and Safety 2016 416-1 Assessment of the health and safety impacts of product and service categories Consumer Issues
Marketing and Labeling
GRI 417 : Marketing and Labeling 2016 417-1 Requirements for product and service information and labeling Information Provision

CSR

CSR
Activities
Report
2017

CSR Activities Report 2017

PDF Download

Mitsubishi
Tanabe
Pharma
Corporate
Report
2017

Corporate Report 2017

PDF Download

ReadSpeaker docReader makes documents accessible to all users including users with vision problems letting users view and listen to texts.
User guide